Correlation Between Valneva SE and Citius Oncology,

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Valneva SE and Citius Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Valneva SE and Citius Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Valneva SE ADR and Citius Oncology,, you can compare the effects of market volatilities on Valneva SE and Citius Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Valneva SE with a short position of Citius Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Valneva SE and Citius Oncology,.

Diversification Opportunities for Valneva SE and Citius Oncology,

0.83
  Correlation Coefficient

Very poor diversification

The 3 months correlation between Valneva and Citius is 0.83. Overlapping area represents the amount of risk that can be diversified away by holding Valneva SE ADR and Citius Oncology, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Citius Oncology, and Valneva SE is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Valneva SE ADR are associated (or correlated) with Citius Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Citius Oncology, has no effect on the direction of Valneva SE i.e., Valneva SE and Citius Oncology, go up and down completely randomly.

Pair Corralation between Valneva SE and Citius Oncology,

Given the investment horizon of 90 days Valneva SE ADR is expected to generate 0.29 times more return on investment than Citius Oncology,. However, Valneva SE ADR is 3.41 times less risky than Citius Oncology,. It trades about -0.05 of its potential returns per unit of risk. Citius Oncology, is currently generating about -0.22 per unit of risk. If you would invest  1,487  in Valneva SE ADR on August 26, 2024 and sell it today you would lose (1,044) from holding Valneva SE ADR or give up 70.21% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthStrong
Accuracy15.09%
ValuesDaily Returns

Valneva SE ADR  vs.  Citius Oncology,

 Performance 
       Timeline  
Valneva SE ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Valneva SE ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's essential indicators remain very healthy which may send shares a bit higher in December 2024. The recent disarray may also be a sign of long period up-swing for the firm investors.
Citius Oncology, 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Citius Oncology, has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in December 2024. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Valneva SE and Citius Oncology, Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Valneva SE and Citius Oncology,

The main advantage of trading using opposite Valneva SE and Citius Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Valneva SE position performs unexpectedly, Citius Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Citius Oncology, will offset losses from the drop in Citius Oncology,'s long position.
The idea behind Valneva SE ADR and Citius Oncology, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators